Stefanou, D. T., Bamias, A., Episkopou, H., Kyrtopoulos, S. A., Likka, M., Kalampokas, T., . . . Souliotis, V. L. (2015). Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer. PLoS One.
Chicago Style CitationStefanou, Dimitra T., et al. "Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer." PLoS One 2015.
Cita MLAStefanou, Dimitra T., et al. "Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer." PLoS One 2015.
Atenció: Aquestes cites poden no estar 100% correctes.